tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cogent announces $200M convertible senior notes, $200M common stock offerings
PremiumThe FlyCogent announces $200M convertible senior notes, $200M common stock offerings
19d ago
Cogent Biosciences: Promising Outlook with Breakthrough GIST Treatment and Strategic Growth Plans
Premium
Ratings
Cogent Biosciences: Promising Outlook with Breakthrough GIST Treatment and Strategic Growth Plans
19d ago
Cogent Biosciences’ Bezuclastinib Shows Promising Phase 3 Results, Boosting Buy Rating and Price Target
Premium
Ratings
Cogent Biosciences’ Bezuclastinib Shows Promising Phase 3 Results, Boosting Buy Rating and Price Target
19d ago
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
PremiumThe FlyMidday Fly By: Insurers slip as Senate spending bill lacks ACA extension
20d ago
Cogent Biosciences’ Phase 3 PEAK Study Success Positions Company for Market Leadership and $1.1 Billion Peak Sales
Premium
Ratings
Cogent Biosciences’ Phase 3 PEAK Study Success Positions Company for Market Leadership and $1.1 Billion Peak Sales
20d ago
Cogent upgraded to Buy at Stifel after ‘overwhelmingly positive’ GIST data
Premium
The Fly
Cogent upgraded to Buy at Stifel after ‘overwhelmingly positive’ GIST data
20d ago
Why Is Cogent Biosciences Stock (COGT) Up 115% Today?
PremiumMarket NewsWhy Is Cogent Biosciences Stock (COGT) Up 115% Today?
20d ago
Cogent Biosciences Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Cogent Biosciences Announces Positive Phase 3 Trial Results
20d ago
Cogent Biosciences reports data from Phase 3 PEAK trial of bezuclastinib
Premium
The Fly
Cogent Biosciences reports data from Phase 3 PEAK trial of bezuclastinib
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100